Severe reaction to diphosphonate: implications for treatment of Paget's disease.
作者信息
Elliott A T, Murray T, Mackie R M, Hunter J A
机构信息
Western Infirmary, Glasgow.
出版信息
BMJ. 1988 Sep 3;297(6648):592-3. doi: 10.1136/bmj.297.6648.592-a.
Abstract
摘要
相似文献
1
Severe reaction to diphosphonate: implications for treatment of Paget's disease.双膦酸盐的严重反应：对佩吉特病治疗的影响
BMJ. 1988 Sep 3;297(6648):592-3. doi: 10.1136/bmj.297.6648.592-a.
2
Paget's disease of bone in patients with gout.
Arch Intern Med. 1986 Dec;146(12):2389-92.
3
Dynamic radionuclide study in Paget's disease before and after (Asu1,7) E-calcitonin treatment.
J Nucl Med Allied Sci. 1984 Jul-Sep;28(3):217-20.
4
Polyostotic Paget's disease.多骨型佩吉特病
J Coll Physicians Surg Pak. 2012 Jul;22(7):461-3.
5
Erythema multiforme reaction to sestamibi.对锝[99mTc]甲氧基异丁基异腈的多形红斑反应
J Nucl Med. 2001 Mar;42(3):534.
6
Delayed-type allergy to technetium Tc 99m.对锝Tc 99m的迟发型过敏反应。
Contact Dermatitis. 1998 Nov;39(5):269-70. doi: 10.1111/j.1600-0536.1998.tb05932.x.
7
[Studies of the kinetics of bone concentration of mdp-tc 99m in Paget's disease and various treatment methods].[佩吉特病中99m锝-亚甲基二膦酸盐骨浓度动力学及各种治疗方法的研究]
Rev Rhum Mal Osteoartic. 1984 Nov;51(10):575-9.
8
Whole-body retention of 99mTc-MPD in Paget's disease.99mTc-MPD在佩吉特病中的全身滞留情况。
J Nucl Med Allied Sci. 1981 Jan-Jun;25(1-2):5-10.
9
[Rosuvastatin-induced erythema multiforme].
Med Clin (Barc). 2013 Jun 4;140(11):523-4. doi: 10.1016/j.medcli.2012.09.035. Epub 2012 Dec 12.
10
Ivory fingers: monostotic Paget's disease of the phalanges.
J Clin Endocrinol Metab. 2007 May;92(5):1590-1. doi: 10.1210/jc.2006-1329.
引用本文的文献
1
Adverse effects of bisphosphonates. A comparative review.双膦酸盐的不良反应。一项比较性综述。
Drug Saf. 1996 Mar;14(3):158-70. doi: 10.2165/00002018-199614030-00003.
2
Erythroderma after clodronate treatment.氯膦酸盐治疗后出现红皮病。
BMJ. 1993 Aug 21;307(6902):484. doi: 10.1136/bmj.307.6902.484.
3
Long-lasting dermatological lesions after tiludronate therapy.替鲁膦酸盐治疗后出现的持久性皮肤病变。
Calcif Tissue Int. 1992 Apr;50(4):378-80. doi: 10.1007/BF00301637.
本文引用的文献
1
Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.联合应用氨基羟丙基二膦酸盐和降钙素治疗癌症相关性高钙血症
Br Med J (Clin Res Ed). 1986 Jun 14;292(6535):1549-50. doi: 10.1136/bmj.292.6535.1549.
2
3
Single high dose aminohydroxypropylidene diphosphonate infusions to treat cancer-associated hypercalcaemia.单次大剂量氨基羟丙基二膦酸盐输注治疗癌症相关性高钙血症。
Lancet. 1986 Jan 18;1(8473):165-6. doi: 10.1016/s0140-6736(86)92309-3.
Zotero 插件